CBD Usage on the Rise
New Study Reveals 1 in 10 Americans Consume CBD Monthly
A recent study highlights that over 10% of Americans have used cannabidiol (CBD) in the past month, with usage rates notably higher among individuals who also consume marijuana. The research underscores the growing popularity of CBD and its potential implications for public health.
New Study Highlights Growing CBD Consumption in the U.S.
A study published in Preventative Medicine Reports analyzed data from the 2022 National Survey on Drug Use and Health (NSDUH), a federally backed survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA). This comprehensive survey gathers information from Americans aged 12 and older regarding substance use, mental health, and related concerns.
According to the analysis by Biola University professor Ji-Yeun Park, 40.7% of individuals who used marijuana within the past 30 days also consumed CBD in the same period. Among those who used marijuana in the past year, 32.2% had taken CBD within the last month. Additionally, 19.1% of individuals who had ever tried marijuana reported recent CBD use.
For those who did not use marijuana, CBD consumption rates were significantly lower:
Non-current marijuana users: 5.09%
Non-past year marijuana users: 4.38%
Individuals who have never used marijuana: 5.09%
Who Uses CBD the Most? Key Demographics
While marijuana use was a key predictor of CBD consumption, other demographic factors also played a role. The study found that adults, white individuals, women, and those reporting fair or poor health were more likely to use CBD than their counterparts.
These findings raise potential health concerns, as previous studies suggest CBD usage might lead to increased marijuana consumption and that combining the two substances could result in significant drug interactions. However, some individuals may be using CBD therapeutically or as a marijuana alternative.
To address these concerns, the researchers recommend public health initiatives to educate consumers on the benefits and risks of CBD, particularly when used alongside marijuana.
Regulatory Challenges and CBD’s Expanding Role
Park’s study is the first to quantify CBD usage within the general U.S. population and explore its connection to marijuana consumption and demographic factors. Since the legalization of hemp under the 2018 Farm Bill, CBD has become widely available, but regulatory challenges remain.
As Congress prepares to draft a new version of the Farm Bill, lawmakers are considering potential changes to hemp regulations. For example, a recent Senate agriculture bill proposes amending how THC levels are measured and aims to reduce regulatory obstacles for hemp farmers.
However, some industry stakeholders worry that the legislation may restrict certain hemp-derived products currently on the market. Similarly, a House Agriculture Committee amendment seeks to redefine legal hemp by excluding cannabinoids synthesized outside of the plant, a move supported by some marijuana companies and prohibition advocates.
Despite these challenges, CBD’s market continues to expand. Recently, DoorDash announced plans to offer hemp-derived THC and CBD products, such as CBD gummies and beverages, in select states.
CBD’s Therapeutic Potential: Pain Management and Addiction Treatment
Emerging research continues to explore CBD’s potential health benefits. A study published last year found that a single 800-milligram dose of CBD could help manage alcohol cravings in individuals with alcohol use disorder (AUD), suggesting its possible role in addiction treatment.
Additionally, a National Institute on Drug Abuse-funded study is examining whether hemp-derived CBD could help individuals with marijuana use disorder reduce their THC consumption. Previous research has indicated that CBD may lower cravings for substances such as heroin and reduce anxiety in individuals with opioid dependence.
Further studies suggest that CBD could serve as an alternative to opioids for pain management. Research published in The Journal of Dental Research in 2023 found that pure CBD was as effective as certain opioid-based medications for alleviating acute dental pain. Another study from the same year reported that legal access to CBD led to a reduction in opioid prescriptions by 6.6% to 8.1%.
The Future of CBD in the U.S.
As CBD gains traction among consumers, continued research into its effects, benefits, and risks remains crucial. With regulatory changes on the horizon and increasing interest in CBD’s therapeutic applications, public awareness and policy developments will play a significant role in shaping the future of CBD use in the United States.
As the industry evolves, education on CBD's proper use, potential interactions, and regulatory shifts will be vital for both consumers and stakeholders. Whether used for pain relief, addiction treatment, or general wellness, CBD is likely to remain a significant player in the health and wellness landscape for years to come.
Click for more news
